Rainbow Childrens Medicare Ltd

Rainbow Child. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rainbow Childrens Medicare Ltd

₹ 1,417 0.55%
10 Jun 4:01 p.m.
rainbowhospitals.in BSE: 543524 NSE: RAINBOW
About

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]

Key Points

Business Overview[1]
The company operates 19 hospitals and 5 clinics across 6 cities, with a total bed capacity of 1,935. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."

Website BSE NSE
  • Market Cap ₹ 14,393 Cr.
  • Current Price ₹ 1,417
  • High / Low ₹ 1,710 / 1,079
  • Stock P/E 59.1
  • Book Value ₹ 145
  • Dividend Yield 0.21 %
  • ROCE 18.9 %
  • ROE 17.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 34.5% CAGR over last 5 years
  • Company's median sales growth is 25.1% of last 10 years

Cons

  • Stock is trading at 9.80 times its book value
  • Working capital days have increased from 95.4 days to 162 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
212 237 313 306 317 287 333 336 341 330 417 398 370
164 155 204 200 219 199 215 218 236 236 270 264 255
Operating Profit 48 82 110 107 98 88 118 118 106 94 147 134 115
OPM % 23% 35% 35% 35% 31% 31% 35% 35% 31% 28% 35% 34% 31%
6 6 8 8 9 8 8 9 13 12 11 13 15
Interest 16 14 13 14 14 15 13 14 17 18 18 18 18
Depreciation 22 22 22 23 23 25 27 28 32 34 35 35 34
Profit before tax 16 52 81 78 70 56 85 85 69 53 105 94 77
Tax % 22% 25% 24% 26% 23% 25% 26% 26% 26% 26% 25% 27% 27%
12 39 62 58 54 42 63 63 51 40 79 69 57
EPS in Rs 1.30 3.76 6.02 5.71 5.28 4.04 6.20 6.12 5.02 3.89 7.77 6.76 5.55
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
122 169 234 321 402 543 719 650 974 1,174 1,297 1,516
98 128 204 266 332 391 519 485 666 774 865 1,026
Operating Profit 24 41 30 55 69 151 201 165 308 400 432 490
OPM % 20% 24% 13% 17% 17% 28% 28% 25% 32% 34% 33% 32%
3 10 16 11 10 8 10 10 19 31 37 51
Interest 3 3 3 3 4 42 48 46 56 58 63 72
Depreciation 13 9 18 22 28 60 69 73 83 90 112 138
Profit before tax 11 38 24 41 47 58 93 56 187 282 295 330
Tax % 53% 35% 28% 24% 22% 22% 41% 29% 26% 25% 26% 26%
5 25 17 31 36 45 55 40 139 212 218 244
EPS in Rs 8.56 26.74 18.22 33.78 8.25 10.14 12.68 9.10 14.70 20.77 21.38 23.97
Dividend Payout % 23% 7% 11% 7% 12% 10% 16% 0% 14% 14% 14% 13%
Compounded Sales Growth
10 Years: 25%
5 Years: 16%
3 Years: 16%
TTM: 17%
Compounded Profit Growth
10 Years: 26%
5 Years: 35%
3 Years: 21%
TTM: 15%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 44%
1 Year: 9%
Return on Equity
10 Years: 17%
5 Years: 20%
3 Years: 20%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 9 9 9 9 44 44 44 44 94 102 102 102
Reserves 144 166 275 308 307 317 350 391 498 958 1,157 1,367
24 22 24 26 24 476 501 529 592 570 765 764
24 34 41 55 73 89 123 116 112 140 146 145
Total Liabilities 201 231 349 399 448 926 1,019 1,081 1,296 1,771 2,170 2,377
56 78 123 174 296 702 702 772 858 931 1,253 1,399
CWIP 4 35 31 7 12 23 43 29 6 23 20 28
Investments 31 7 2 6 0 3 10 18 22 58 308 571
109 111 194 212 140 199 265 262 409 759 590 380
Total Assets 201 231 349 399 448 926 1,019 1,081 1,296 1,771 2,170 2,377

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
15 26 17 36 48 127 170 143 224 329 321 396
-113 -20 -107 -33 -42 -117 -117 -83 -175 -465 -226 -268
98 -7 93 -1 -7 -9 -52 -61 -44 143 -102 -118
Net Cash Flow -0 -1 3 1 -2 2 2 -1 4 7 -7 10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 10 11 10 16 14 24 22 25 15 16 20 19
Inventory Days 25 39 35 48 36 32 55 36 28 43 53 52
Days Payable 128 121 107 142 151 197 202 190 121 182 180 170
Cash Conversion Cycle -93 -72 -62 -79 -100 -141 -124 -130 -78 -123 -107 -100
Working Capital Days -25 -27 -32 -23 -29 -20 -6 -9 -7 76 48 162
ROCE % 22% 11% 14% 14% 16% 16% 11% 23% 24% 19% 19%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
49.83% 49.83% 49.83% 49.83% 49.83% 49.83% 49.83% 49.83% 49.87% 49.85% 49.85% 49.85%
22.97% 15.89% 20.82% 19.82% 20.20% 21.63% 22.32% 24.04% 24.78% 25.12% 25.12% 23.69%
9.44% 10.25% 13.90% 15.38% 15.36% 15.39% 15.62% 14.76% 13.81% 13.84% 13.87% 15.31%
17.76% 24.02% 15.45% 14.98% 14.63% 13.14% 12.23% 11.37% 11.53% 11.20% 11.16% 11.14%
No. of Shareholders 1,66,06491,53079,22475,61174,69079,18780,47177,15278,55777,52478,76479,092

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls